Safety/Quality

Latest Issue of OR Manager
March 2025
Home Safety/Quality

Report: US hospitals see sevenfold improvement in hand hygiene compliance since 2020

Editor's Note According to this report published by The Leapfrog Group this month, hospitals in the US have significantly improved hand hygiene compliance, with 74% meeting the Leapfrog Hand Hygiene Standard in 2023, up from 11% in 2020. Among other factors, the report attributes this improvement to increased use of…

Read More

By: Tarsilla Moura
September 24, 2024
Share

Study: OR noise raises risk of surgical error

Editor's Note Often exceeding federal safety limits, OR noise contributes significantly to communication breakdowns, heightened cognitive load, and increased surgical errors, according to a review of literature published September 17 in Cureus. Identified noise sources include surgical instruments, alarms, and staff conversations, which can reach up to 120 decibels (dBA)—a…

Read More

By: Matt Danford
September 23, 2024
Share

Alternative to mitral valve surgery shows promise, but research criticized

Editor's Note Although data suggest transcatheter edge-to-edge repair (TEER) using the MitraClip device may offer similar outcomes to mitral valve surgery in patients with heart failure and functional mitral regurgitation (FMR), experts have criticized the research, TCT MD reported September 1. Presented at the recent European Society of Cardiology (ESC)…

Read More

By: Matt Danford
September 23, 2024
Share

California updates guidance on CRNA scope of practice

Editor's Note Confusion about the scope of practice for Certified Registered Nurse Anesthetists (CRNAs) prompted The California Department of Public Health to update guidelines for acute care hospitals, MedPage Today reported September 18. Issued after violations at two Modesto hospitals resulted in hundreds of cancelled surgeries, a letter from the…

Read More

By: Matt Danford
September 20, 2024
Share

Sponsored Message

FDA designates Class 1 recall for tracheostomy tubes

Editor's Note The US Food and Drug Administration (FDA) has designated the recall of Smiths Medical’s Bivona Neonatal/Pediatric and Adult Tracheostomy tubes as a Class 1, the most severe category indicating risk of serious injury or death. According to the agency’s September 18 report, the recall is due to a…

Read More

By: Matt Danford
September 19, 2024
Share

Study: Preventing antibiotic-resistant infection surge could save millions

Editor's Note Research shows antibiotic-resistant infections could lead to 8.2 million deaths annually by 2050, representing a 75% increase from current rates, according to a September 17 article in HealthDay. Published in the Lancet, the new study highlights the growing threat of growing threat of antimicrobial resistance (AMR), predicting that…

Read More

By: Matt Danford
September 19, 2024
Share

Sponsored Message

Face transplant survival rates “encouraging,” global study finds

Editor's Note Nearly 20 years of data on the first 50 face transplants in the world indicate that survival rates exceed those of several solid organ transplants, according to a global study published September 18 in Jama Surgery. Conducted between 2005 and 2021, the study involved 18 transplant centers, assessed…

Read More

By: Matt Danford
September 19, 2024
Share

Study: Adjuvant nivolumab reduces risk of death, lung cancer recurrence

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

By: Matt Danford
September 18, 2024
Share

Analysis: Hospital safety, quality measures surpass pre-pandemic levels

Editor's Note An American Hospital Association (AHA) analysis of data from Vizient reveals that hospital performance levels in the first quarter of this year was on par with performance prior to the COVID-19 pandemic, despite patients exhibiting more significant healthcare needs. Released this month, the report analyzes data from 2019…

Read More

By: Matt Danford
September 17, 2024
Share

FDA: Class 1 infusion system recall expanded

Editor's Note B. Braun Medical Inc. has expanded last year’s recall of lnfusomat Space Infusion Pump systems to include more models. Designated by the US Food and Drug Administration (FDA) as Class 1—the most serious category indicating risk of severe injury or death—the recall was motivated by the risk of…

Read More

By: Matt Danford
September 17, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat